331 related articles for article (PubMed ID: 12200801)
1. Ovarian manifestations in women with autosomal dominant polycystic kidney disease.
Heinonen PK; Vuento M; Maunola M; Ala-Houhala I
Am J Kidney Dis; 2002 Sep; 40(3):504-7. PubMed ID: 12200801
[TBL] [Abstract][Full Text] [Related]
2. Frequency of ovarian cysts in patients with autosomal dominant polycystic kidney disease.
Stamm ER; Townsend RR; Johnson AM; Garg K; Manco-Johnson M; Gabow PA
Am J Kidney Dis; 1999 Jul; 34(1):120-4. PubMed ID: 10401025
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease.
Sherstha R; McKinley C; Russ P; Scherzinger A; Bronner T; Showalter R; Everson GT
Hepatology; 1997 Nov; 26(5):1282-6. PubMed ID: 9362373
[TBL] [Abstract][Full Text] [Related]
4. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
[TBL] [Abstract][Full Text] [Related]
5. Abdominal sonographic study of autosomal dominant polycystic kidney disease.
Nicolau C; Torra R; Bianchi L; Vilana R; Gilabert R; Darnell A; Brú C
J Clin Ultrasound; 2000; 28(6):277-82. PubMed ID: 10867665
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.
Bae KT; Zhu F; Chapman AB; Torres VE; Grantham JJ; Guay-Woodford LM; Baumgarten DA; King BF; Wetzel LH; Kenney PJ; Brummer ME; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
Clin J Am Soc Nephrol; 2006 Jan; 1(1):64-9. PubMed ID: 17699192
[TBL] [Abstract][Full Text] [Related]
7. Renal ultrasonographic evaluation in children at risk of autosomal dominant polycystic kidney disease.
Reed B; Nobakht E; Dadgar S; Bekheirnia MR; Masoumi A; Belibi F; Yan XD; Cadnapaphornchai M; Schrier RW
Am J Kidney Dis; 2010 Jul; 56(1):50-6. PubMed ID: 20452711
[TBL] [Abstract][Full Text] [Related]
8. [Clinical diagnosis of Autosomal Dominant Polycystic Kidney Disease].
Magistroni R; Izzi C; Scolari F
G Ital Nefrol; 2016; 33(2):. PubMed ID: 27067212
[TBL] [Abstract][Full Text] [Related]
9. Intracranial cysts in autosomal dominant polycystic kidney disease.
Schievink WI; Huston J; Torres VE; Marsh WR
J Neurosurg; 1995 Dec; 83(6):1004-7. PubMed ID: 7490613
[TBL] [Abstract][Full Text] [Related]
10. Autosomal dominant polycystic kidney disease: MR imaging evaluation using current techniques.
Mosetti MA; Leonardou P; Motohara T; Kanematsu M; Armao D; Semelka RC
J Magn Reson Imaging; 2003 Aug; 18(2):210-5. PubMed ID: 12884334
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate antigen 19-9 is significantly elevated in autosomal dominant polycystic kidney disease.
Fukasawa H; Kaneko M; Niwa H; Yasuda H; Kumagai H; Furuya R
Nephrology (Carlton); 2018 Mar; 23(3):210-216. PubMed ID: 28024168
[TBL] [Abstract][Full Text] [Related]
12. Autosomal dominant polycystic kidney disease.
Srivastava A; Patel N
Am Fam Physician; 2014 Sep; 90(5):303-7. PubMed ID: 25251090
[TBL] [Abstract][Full Text] [Related]
13. Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control study. The U.C.L. Collaborative Group.
Christophe JL; van Ypersele de Strihou C; Pirson Y
Nephrol Dial Transplant; 1996 Jul; 11(7):1271-6. PubMed ID: 8672022
[TBL] [Abstract][Full Text] [Related]
14. Sonographic pattern of recessive polycystic kidney disease in young adults. Differences from the dominant form.
Nicolau C; Torra R; Badenas C; Pérez L; Oliver JA; Darnell A; Brú C
Nephrol Dial Transplant; 2000 Sep; 15(9):1373-8. PubMed ID: 10978393
[TBL] [Abstract][Full Text] [Related]
15. Effect of lanreotide on polycystic liver and kidneys in autosomal dominant polycystic kidney disease: an observational trial.
Gevers TJ; Hol JC; Monshouwer R; Dekker HM; Wetzels JF; Drenth JP
Liver Int; 2015 May; 35(5):1607-14. PubMed ID: 25369108
[TBL] [Abstract][Full Text] [Related]
16. Association of kidney and cysts dimensions with anthropometric and biochemical parameters in patients with ADPKD.
Pietrzak-Nowacka M; Safranow K; Palacz J; Gołembiewska E; Marchelek-Myśliwiec M; Ciechanowski K
Ren Fail; 2015 Jun; 37(5):798-803. PubMed ID: 25869055
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous transcatheter hepatic artery embolization for liver cysts in autosomal dominant polycystic kidney disease.
Takei R; Ubara Y; Hoshino J; Higa Y; Suwabe T; Sogawa Y; Nomura K; Nakanishi S; Sawa N; Katori H; Takemoto F; Hara S; Takaichi K
Am J Kidney Dis; 2007 Jun; 49(6):744-52. PubMed ID: 17533017
[TBL] [Abstract][Full Text] [Related]
18. Extrarenal manifestations of autosomal dominant polycystic kidney disease.
Ha SK; Park CH; Kna JS; Lee SY; Lee JI; Kim SJ; Seo JK; Lee HY; Han DS
Yonsei Med J; 1997 Apr; 38(2):111-6. PubMed ID: 9175489
[TBL] [Abstract][Full Text] [Related]
19. Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease.
Grampsas SA; Chandhoke PS; Fan J; Glass MA; Townsend R; Johnson AM; Gabow P
Am J Kidney Dis; 2000 Jul; 36(1):53-7. PubMed ID: 10873872
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonographic study of pancreatic cysts in autosomal dominant polycystic kidney disease.
Torra R; Nicolau C; Badenas C; Navarro S; Pérez L; Estivill X; Darnell A
Clin Nephrol; 1997 Jan; 47(1):19-22. PubMed ID: 9021236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
